MR
Last reporting period 30 Jun, 2024
Updated 18 Sep, 2024
Last price
—
Market cap $B
299.84
Exchange
XNYS - New York Stock Exchange, Inc
11.4 B
Last period Cash and equivalents ,USD
60%
Cash and equivalents has increased in 5 years
What is Cash and equivalents ?
Cash is the amount of free cash on the company's accounts, as well as short-term liquid investments.
See also Merck
Company Analysis
MRK valuation, rating, competitors, insights and company profile
Eyestock Rating
MRK financial analysis by Eyestock methodology
Valuation
MRK valuation using historical relative method
Statements
MRK Income Statements, Balance Sheet and Cash Flow Statements
Dividends
MRK dividend yield and annual dividend
Cash is the amount of free cash on the company's accounts, as well as short-term liquid investments.
Merck`s Cash and equivalents for the period ended 2024-06-30 are 11.4 B USD
